Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cytokines gene expression in newly diagnosed multiple sclerosis patients.
From the periphery to the brain: Lipocalin-2, a friend or foe?
Glial cell biology in the Great Lakes region.
Prorating WAIS-IV Summary Scores for Patients with Relapsing-Remitting Multiple Sclerosis.
Myelin-specific T cells induce interleukin-1beta expression in lesion-reactive microglial-like cells in zones of axonal degeneration.
The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.
A single-group pilot feasibility study of cognitive behavioural therapy in people with multiple sclerosis with depressive symptoms.
Multicontrast MR Imaging at 7T in Multiple Sclerosis: Highest Lesion Detection in Cortical Gray Matter with 3D-FLAIR.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency in people with multiple sclerosis: a summary of a Cochrane systematic review.
Culturing microglia from the neonatal and adult central nervous system.
Determining the Presence of Reliable Change over Time in Multiple Sclerosis: Evidence from the PASAT, Adjusting-PSAT, and Stroop Test
Epigenetic changes in inflammatory and autoimmune diseases.
Immunological follow-up of patients with neuromyelitis optica: Is there a good biomarker?
How do autoimmune diseases cluster in families? A systematic review and meta-analysis.
Combining Self-help and Professional Help to Minimize Barriers to Physical Activity in Persons With Multiple Sclerosis: A Trial of the "Blue Prescription" Approach in New Zealand.
Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases.
MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge.
Review: In relapsing-remitting multiple sclerosis, disease-modifying agents reduce annual relapse rates.
Acute disseminated encephalomyelitis mimicking acute meningoencephalitis.
IL1-β expression in multiple sclerosis.
Health effects of lesion localization in multiple sclerosis: spatial registration and confounding adjustment.
The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factors.
Self-report versus performance measure in gauging level of function with multiple sclerosis.
Treatment of relapsing-remitting multiple sclerosis: current and future algorithms.
11C-Acetate PET Imaging in Patients with Multiple Sclerosis.
Pages
« first
‹ previous
…
435
436
437
438
439
440
441
442
443
…
next ›
last »